Cord Blood Banking Services Market Analysis 2026

Market dynamics of Cord Blood Banking Services: 

Key Drivers of the Cord Blood Banking Services Market

• An increase in Chronic Diseases and Haematological Disorders will fuel demand for Cold Blood Banking Services -

The government's funding and investments for public storage, the rise in chronic disease deaths, the expansion of research initiatives aimed at developing cord blood applications, and the growing public consciousness of the widespread use of cutting-edge treatments are just a few of the factors propelling the growth of the cord blood and cell banking market during the forecast period. There is a link between the hematological illness and blood and the organs that generate blood. The prevalence of these diseases is rising, including hemophilia, thalassemia, sickle cell anemia, leukemia, and lymphoma.  According to World Federation of Hemophilia, United States accounted for 11,790 cases of hemophilia A and 3,026 cases of hemophilia B in 2020.
(Source- https://www1.wfh.org/publications/files/pdf-2045.pdf )

The global leukemia case rate is sharply rising, which is fueling the demand for cord blood cells. According to the National Cancer Institute, Leukemia represents 3.0% of all new cancer cases in the U.S. 
(Source- https://seer.cancer.gov/statfacts/html/leuks.html)

Thus, an increase in chronic diseases and hematological disorders will drive the market for Cold Blood Banking Services.

• Increasing Knowledge of the Therapeutic Potential of Stem Cells will have a positive effect on the demand for Cold Blood banking services-

The general public's understanding of stem cells' potential for therapeutic applications is expanding as more clinical data becomes available. Moreover, several illnesses and ailments, including cancer, immunodeficiency diseases, metabolic disorders, and degenerative neuromuscular disorders, are successfully treated with stem cells. The continued rise in per capita disposable income in developing countries and the anticipated decline in the cost of the products used in conjunction with these treatments are expected to contribute to an increase in public awareness and adoption of stem cell therapies throughout the study period, as well as stem cell banking services. Due to increased knowledge among expectant parents, cord blood banking has quickly grown throughout all continents. In developing countries like Brazil, China, and India, a plethora of public and private organizations are initiating awareness campaigns. Thus, increasing knowledge of the therapeutic potential of stem cells will have a positive effect on the demand for cold blood banking services. 

• Increasing R&D will lead to greater demand for Cord Blood Banking Services-

Over the course of the forecast period, rising research and development in the area of using cord blood for the treatment of chronic diseases is anticipated to fuel the expansion of the global cord blood banking services market. For example, on May 11, 2021, the SingHealth Group, a Singapore-based healthcare institution, at the SingHealth Duke-NUS Academic Medical Centre (AMC), conducted a first-in-man study in Singapore using a novel technology that increases the number of blood-forming stem cells from stored umbilical cord blood (UCB) in partnership with Cordlife Group Limited, a consumer health company based in Singapore. This is the first human trial for UCB cell therapy generated in-house.
Source- https://www.singhealth.com.sg/news/tomorrows-medicine/singhealth-duke-nus-academic-medical-centre-and-cordlife-partner-to-advance-stem-cell-technology-to-first-in-man-clinical-trial-in-singapore 

Research and development is being done to support the clinical viewpoint. This includes defining the cellular threshold for engraftment, creating transplantation protocols for adult patients, accelerating engraftment using single-cell expansion and homing technologies, creating individualized protocols to increase efficacy, using adoptive cell therapy to lessen the effects of delayed immune reconstitution, and utilizing cutting-edge therapies to further enhance the graft-versus-leukemia effect. Consequently, increasing R&D will lead to greater demand for cord blood banking services.

Restraints of the Cord Blood Banking Services Market

• Extensive Regulations and Substantial Costs will impede market growth-

Even though it has been shown that drawing cord blood is safe and painless for both the mother and the child, employing this service can be hindered by the high cost of private banking, especially in developing and underdeveloped countries. Among these paid services are contamination, typing, and testing for infectious illnesses. The stringent laws and norms governing services for cord blood banking represent another major barrier to this company's expansion. Furthermore, it is expected that the lengthy licencing and approval process required to establish stem cell banks in developed nations, coupled with the increasingly stringent and mandatory regulatory requirements for stem cell preservation and banking, will raise the overall operating costs for stem cell banking service providers. Thus, stringent regulations and substantial costs will restrict market growth.

Opportunities of the Cord Blood Banking Services Market

• A High Incidence of Genetic Disorders and an Increase in Government Funding-

The main purpose of cord blood banking services is to treat genetic illnesses like cancer and other conditions. The rising incidence of different cancers is expected to drive growth in the market for cord blood banking services. Cases of sarcoma, leukaemia, immune system problems, and lymphoma have surged in the past several years in countries including the US, China, India, and Europe. According to the National Center for Biotechnology Information, there are about 248,724 non-Hodgkin lymphoma-related deaths and 509,590 new cases of the disease. 
(Source-https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494781/#:~:text=According%20to%20the%20Global%20Cancer,36%20cancers%20involved%20(3). )

Thus, as the number of cancer patients rises, so does the need for cord blood banking services. 

Impact of COVID-19 on the Cord Blood Banking Services Market

The COVID-19 pandemic altered the supply and demand for pharmaceuticals, disrupted the supply chain, and had a negative financial impact on businesses and financial markets. Numerous nations, including China, India, Saudi Arabia, the United Arab Emirates, Egypt, and others, experienced difficulties with drug shipment due to nationwide lockdowns. Many companies in the global cord blood banking services market had to temporarily suspend operations due to the COVID-19 pandemic in order to comply with new government rules aimed at curbing the disease's spread. The worldwide market for cord blood banking services was immediately impacted by this operational stoppage in terms of income flow. A stoppage in the production of industrial goods also occurs during the lockdown because of a shortage of labor and raw supplies. Moreover, businesses in this industry do not accept any new shipments. Therefore, the worldwide cord blood banking services industry has been impacted by a halt in industrial activity and lockdowns for several months. As a result, the market had a gradual recovery over the projection period. Additionally, the global cord blood banking services market was adversely affected by the COVID-19 epidemic, primarily because fewer people were donating and receiving cord blood. 
 

Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.

The Global Cord Blood Banking Services Market is witnessing significant growth in the near future.

In 2023, the Private segment accounted for noticeable share of global Cord Blood Banking Services Market and is projected to experience significant growth in the near future.

The Cancer segment is expected to expand at the significant CAGR retaining position throughout the forecast period.

Some of the key companies Cordlife Group Limited , Cryo-Cell International Inc. and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.

Frequently Asked Questions (FAQs)